Karl Strpklin's  Instablog

Karl Strpklin
Send Message
  • BA, PWRM, OSHC, CACI - DoubleInStocks.com Stock Report! Nov 3rd 2010 0 comments
    Nov 3, 2010 2:10 PM | about stocks: CACI, BA, OPTT

    money 1
    signup3m

    power3 PWRM, Power 3 Medical Products Inc., PWRM.OB

    PWRM is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.

    PWRM’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, drug targets, and its diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro).

    PWRM continues to evolve and enhance its IP portfolio, employing sensitive and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of highly selective blood-based tests for ALS (Lou Gehrig’s disease), Alzheimer’s, Parkinson’s diseases, breast cancer, and drug resistance.

    The NuroPro Blood Test is PWRM’s diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease .

    PWRM’s BC-SeraPro(NYSE:TM) is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient’s serum sample is compared to PWRM’s patient database. Statistical analysis by linear discriminant function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis. Probability score is ranged from 0.0 to 1.0. Results of PWRM’s BC-SeraPro(TM) test should not be considered a stand alone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.

    PWRM expects to complete phase II clinical validation trials of its blood serum diagnostics for Alzheimer’s disease (NuroPro-AD), Parkinson’s disease (NuroPro-PD) and breast cancer in 2010, followed by filings with the FDA.

    www.power3medical.com

    _____

    Boeing (NYSE:BA) announced the availability of a rotable exchange services program, that will support the operation of the Boeing 787 Dreamliner. This program will help airline customers reduce inventory costs by providing access to a Boeing-managed inventory pool of parts that is available to ship within 24 hours of request.

    The Boeing Company designs, develops, manufactures, sells, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight, and launch systems and services worldwide

    _____

    Ocean Shore Holding Co. (NASDAQ:OSHC) announced net income of $1,441,000, or $0.21 per diluted share, for the quarter ended September 30, 2010, as compared to $1,313,000, or $0.18 per diluted share, for the quarter ended September 30, 2009. Net income for the nine months ended September 30, 2010 was $4,016,000, or $0.59 per diluted share, as compared to $2,897,000, or $0.41 per diluted share, for the same period in 2009.

    Ocean Power Technologies, Inc. (Nasdaq:OPTT) announces that the US Navy has awarded $2.75 million in additional funding to OPT for a second stage under its existing contract to provide an autonomous PowerBuoy® wave energy conversion system for the Navy’s near-coast anti-terrorism and maritime surveillance program.

    Ocean Power Technologies, Inc. (Nasdaq:OPTT) is a pioneer in wave-energy technology that harnesses ocean wave resources to generate reliable, clean and environmentally-beneficial electricity.

    _____

    CACI International Inc (NYSE: CACI) announced that it has been awarded a $45 million task order contract to provide program management and technical engineering services to upgrade Common Ground Systems (CGS) with subsystems from the U.S. Army’s Distributed Common Ground System-Army (DCGS-A) Ground Mobile system.

    CACI provides professional services and IT solutions needed for defense, intelligence, homeland security, and IT modernization and government transformation.

    _____

    THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

    Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DoubleInStocks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. (Read more at: http://doubleinstocks.com/disclaimer) Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).

    Sign Up for our FREE Daily Stock Newsletter

    http://doubleinstocks.com/img/doubleinstocks_buscard.jpg


    ctse16

    DoubleInStocks would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com


    Stocks: CACI, BA, OPTT
Back To Karl Strpklin's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

Latest Comments


Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.